Covidien Expands Oximetry Biz With Somanetics Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Covidien will expand its oximetry offerings through the purchase of Invos patient monitor manufacturer Somanetics for $250 million
You may also be interested in...
Covidien Gains Capnography Market Leader Oridion Via $300 Mil. Acquisition
Newly acquired Oridion Microstream exhaled carbon dioxide measurement technology dovetails with Covidien’s pulse oximetry and other patient monitoring products.
Covidien Gains Barrett’s Esophagus Ablation Device Via Barrx Acquisition
Deal worth $325 million bolsters Covidien’s energy-based product offerings with Barrx Medical’s radiofrequency energy-based HaloFlex system for preventing esophageal cancer.
Earnings Calls In Brief
Hologic 3D mammography